Use Able AI chat for product recommendations

ChemBright CoraLite® Plus 700 Antibody Conjugation Kit

Cat No. PK30037

Applications

FC, IF/ICC, WB

Conjugate

CoraLite® Plus 700

Size: 

-/ -


ご購入について

国内販売は「コスモ・バイオ株式会社」を通じて行っております。お見積り・ご注文はお近くの販売代理店へご連絡ください。


国内在庫・納期について

約2万点のプロテインテック製品をコスモバイオ社物流センター(国内)に在庫しています。国内在庫の有無はコスモバイオ社ホームページの「品番検索」でカタログ番号を検索して確認できます。


保証・サポートについて

テクニカルサポートまたはご購入後1年間の交換/補填対応を承ります。詳細はこちらをご覧ください。


Product Information

Fluorescently-labeled antibodies can be used for a variety of immunoassays such as immunohistochemistry, immunocytochemistry, flow cytometry, and fluorescent Western blot.  

This antibody conjugation kit is designed to covalently conjugate CoraLite® Plus 700 to antibodies in 1-2 hours. Conjugated antibodies can be used immediately or stored at 4°C for up to 12 months. This kit is suitable for three reactions of labeling 100 ug primary antibody.  

Antibody requirements: This kit is compatible with IgGs at 1 mg/mL in carrier-free buffer (PBS) with <0.1% BSA. Antibody buffer must be azide and glycerol-free. 


Technical Principles: 

The ChemBright product series is developed based on maleimide chemistry and represents innovative upgrades over conventional technologies.

Traditional maleimide conjugation relies on reductive cleavage of interchain disulfide bonds in antibodies to expose thiol groups for subsequent conjugation. However, excess reducing agents in the system tend to cause over-reduction and structural fragmentation of antibodies, generating biologically inactive antibody fragments and compromising the quality of labeled conjugates.

The NHS ester conjugation method reacts with primary amines (–NH₂) on the antibody surface to form stable amide bonds.

ChemBright technology does not require reduction of antibody disulfide bonds. Instead, it specifically converts primary amines on antibody lysine residues into reactive thiol groups (4–6 thiols), fundamentally eliminating antibody inactivation caused by over-reduction. This approach removes the need for scavenging excess reducing agents, streamlines workflows, and substantially improves the yield and bioactivity of conjugated antibodies.


Components

Component

Catalog No.

Size

Vial A: Antibody Modifier Reagent

PK3003X-A

3*100 ug

Vial B: Lyophilized CoraLite® Plus 700

PK30037-B

3*100 ug

Storage Vial C

PK3003X-C

3*100 ug

Quenching Reagent

PK3003X-Q

200 uL

Storage

Store at room temperature (20-25℃) in the dark.

Usage

Note: Before you begin, equilibrate primary antibody to room temperature. Primary antibody should be in carrier-free buffer (PBS) at 1 mg/mL with <0.1% BSA. Spin down Vial A (Antibody Modifier Reagent) and Vial B (lyophilized dye) to ensure that lyophilized contents are at the bottom of the tube. 

Protocol:

1. Add 100 ug of primary antibody to Vial A (lyophilized Antibody Modifier Reagent). Pipette to mix.

2. Incubate for 15 min at RT. 

3. Transfer entire contents of Vial A to Vial B (lyophilized dye). Pipette to mix. 

4. Rotate for 30 minutes to 1 hour at RT. Protect from light. Spin down Vial B.  

5. Add 20 uL of Quenching Reagent to Vial B. Transfer entire contents of Vial B to Storage Vial C. Pipette to mix. 

6. Incubate for 10 minutes. Conjugated antibody is now ready to use.  

Picture Protocol:

Graphical protocol-ChemBright Antibody Conjugation Kit

Additional Information

1. Titrations of the conjugated antibody are recommended to find the optimal antibody dilution for your application.  

2. Store conjugated antibody in Vial C sealed at 4°C. Blank labels are provided to label Vial C.

3. It is recommended to add a preservative such as sodium azide to the conjugated antibody for long-term storage.

4. The estimated final concentration of the conjugated antibody is 0.83 mg/mL.

Cited in Article as

pk30037, ChemBright CoraLite® Plus 700 Antibody Conjugation Kit, Proteintech, IL, USA

{{ptg:customerreview}}
||
New chat

Able™

正在加载,请稍候...